Abstract
With the in vivo demonstration of somatostatin-receptor-positive tumors in patients using a radiolabeled somatostatin analog, peptide receptor scintigraphy became available some 15 yr ago. Octreoscan® is a radiopharmaceutical with proven clinical importance in the visualization of somatostatin-receptor-positive tumors, and the overall sensitivity of somatostatin receptor imaging is high. In a number of neuroendocrine tumor types, as well as in Hodgkin’s disease, inclusion of somatostatin receptor imaging in the localization or staging procedure may be very rewarding. The value of somatostatin receptor imaging in patients with other tumors, like breast cancer, or in patients with granulomatous diseases, has to be established.
Similar content being viewed by others
References
Krenning, E. P., Bakker, W. H., Breeman, W. A., et al. (1989). Lancet 1(8632), 242–244.
Brazeau, P., Vale, W., Burgus, R., et al. (1973). Science 179 (68), 77–79.
Lamberts, S. W., Krenning, E. P., and Reubi, J. C. (1991). Endocr. Rev. 12(4), 450–482.
Liapakis, G., Fitzpatrick, D., Hoeger, C., Rivier, J., Vandlen, R., and Reisine, T. (1996). J. Biol. Chem. 271(34), 20331–20339.
Martin, J. L., Chesselet, M. F., Raynor, K., Gonzales, C., and Reisine, T. (1991). Neuroscience 41(2–3), 581–593.
O’Carroll, A. M., Raynor, K., Lolait, S. J., and Reisine, T. (1994). Mol. Pharmacol. 46(2), 291–298.
Reisine, T. and Bell, G. I. (1995). Neuroscience 67(4), 777–790.
Reisine, T. (1995). Am. J. Physiol. 269(6 Pt. 1), G813-G820.
Schaer, J. C., Waser, B., Mengod, G., and Reubi, J. C. (1997). Int. J. Cancer 70(5), 530–537.
Reubi, J. C. (1997). Endocr. Pathol. 8(1), 11–20.
Reubi, J. C., Schaer, J. C., Markwalder, R., Waser, B., Horisberger, J., and Laissue, J., et al. (1997). Biol. Med. 70(5–6), 471–479.
Reubi, J. C., Laissue, J., Krenning, E., and Lamberts, S. W. (1992). J. Steroid Biochem. Mol. Biol. 43(1–3), 27–35.
Reubi, J. C., Krenning, E., Lamberts, S. W., and Kvols, L. (1992). Metabolism 41(9 Suppl. 2), 104–110.
Reubi, J. C., Waser, B., Khosla, S., et al. (1992). J. Clin. Endocrinol. Metab. 74(5), 1082–1089.
Reubi, J. C., Waser, B., van Hagen, M., et al. (1992). Int. J. Cancer 50(6), 895–900.
Reubi, J. C. (1992). Yale J. Biol. Med. 65(5), 493–503; discussion 531.
Reubi, J. C., Waser, B., van Hagen, M., et al. (1992). Int. J. Cancer 50(6), 895–900.
Reubi, J. C., Waser, B., Khosla, S., et al. (1992). J. Clin. Endocrinol. Metab. 74(5), 1082–1089.
Reubi, J. C. (1997). Q. J. Nucl. Med. 41(2), 63–70.
Denzler, B. and Reubi, J. C. (1999). Cancer 85(1), 188–198.
Reubi, J. C., Waser, B., Schaer, J. C., and Laissue, J. A. (2001). Eur. J. Nucl. Med. 28(7), 836–846.
Vanhagen, P. M., Krenning, E. P., Reubi, J. C., et al. (1994). Eur. J. Nucl. Med. 21(6), 497–502.
Reubi, J. C., Waser, B., Markusse, H. M., Krenning, E. P., VanHagen, M., and Laissue, J. A. (1994). Eur. J. Pharmacol. 271(2–3), 371–378.
Reubi, J. C., Mazzucchelli, L., and Laissue, J. A. (1994). Gastroenterology 106(4), 951–959.
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., et al. (1993). Eur. J. Nucl. Med. 20(8), 716–731.
Menda, Y. and Kahn, D. (2002). Semin. Nucl. Med. 32(2), 92–96.
Lebtahi, R., Le Cloirec, J., Houzard, C., et al. (2002). J. Nucl. Med. 43(7), 889–895.
Reubi, J. C., Schar, J. C., Waser, B., et al. (2000). Eur. J. Nucl. Med. 27(3), 273–282.
Virgolini, I., Britton, K., Buscombe, J., Moncayo, R., Paganelli, G., and Riva, P. (2002). Semin. Nucl. Med. 32(2), 148–155.
Jamar, F., Fiasse, R., Leners, N., and Pauwels, S. (1995). J. Nucl. Med. 36(4), 542–549.
Gibril, F., Reynolds, J. C., Chen, C. C., et al. (1999). J. Nucl. Med. 40(4), 539–553.
Reubi, J. C., Horisberger, U., Studer, U. E., Waser, B., and Laissue, J. A. (1993). J. Clin. Endocrinol. Metab. 77(5), 1323–1328.
Legovini, P., De, M. E., Billeci, D., Conti, B., Zoli, P., and Conte, N. (1997). J. Endocrinol. Invest. 20(7), 424–428.
Duet, M., Ajzenberg, C., Benelhadj, S., et al. (1999). J. Nucl. Med. 40(8), 1252–1256.
de Bruin, T. W., Kwekkeboom, D. J., Van’t Verlaat, J. W., et al. (1992). J. Clin. Endocrinol. Metab. 75(5), 1310–1317.
Merola, B., Colao, A., Ferone, D., et al. (1993). Horm. Res. 40(4), 149–155.
Kwekkeboom, D. J., de Herder, W. W., and Krenning, E. P. (1999). J. Endocrinol. Invest. 22(1), 80–88.
de Kerviler, E., Cadiot, G., Lebtahi, R., Faraggi, M., Le Guludec, D., and Mignon, M. (1994). Eur. J. Nucl. Med. 21(11), 1191–1197.
Gibril, F., Reynolds, J. C., Doppman, J. L., et al. (1996). Ann. Intern. Med. 125(1), 26–34.
Zimmer, T., Scherubl, H., Faiss, S., Stolzel, U., Riecken, E. O., and Wiedenmann, B. (2000). Digestion 62(Suppl. 1), 45–50.
Zimmer, T., Stolzel, U., Bader, M., et al. (1996). Gut 39(4), 562–568.
Rosch, T., Lightdale, C. J., Botet, J. F., et al. (1992). N. Engl. J. Med. 326(26), 1721–1726.
Lightdale, C. J., Botet, J. F., Woodruff, J. M., and Brennan, M. F. (1991). Cancer 68(8), 1815–1820.
Lebtahi, R., Cadiot, G., Sarda, L., et al. (1997). J. Nucl. Med. 38(6), 853–858.
Kwekkeboom, D. J., Krenning, E. P., Bakker, W. H., Oei, H. Y., Kooij, P. P., and Lamberts, S. W. (1993). Eur. J. Nucl. Med. 20(4), 283–292.
Kalkner, K. M., Janson, E. T., Nilsson, S., Carlsson, S., Oberg, K., and Westlin, J. E. (1995). Cancer Res. 55(23 Suppl.), 5801S-5804S.
Westlin, J. E., Janson, E. T., Arnberg, H., Ahlstrom, H., Oberg, K., and Nilsson, S. (1993). Acta Oncol. 32(7–8), 783–786.
Kvols, L. K. (1994). Ann. NY Acad. Sci. 733, 464–470.
Kvols, L. K. (1993). Gastroenterology 105(6), 1909–1911.
Kwekkeboom, D. J., van Urk, H., Pauw, B. K., et al. (1993). J. Nucl. Med. 34(6), 873–878.
Kwekkeboom, D. J., Reubi, J. C., Lamberts, S. W., et al. (1993). J. Clin. Endocrinol. Metab. 76(6), 1413–1417.
Tisell, L. E., Ahlman, H., Wangberg, B., et al. (1997). Br. J. Surg. 84(4), 543–547.
Adams, S., Baum, R. P., Hertel, A., Schumm-Draeger, P. M., Usadel, K. H., and Hor, G. (1998). Eur. J. Nucl. Med. 25(9), 1277–1283.
Postema, P. T., de Herder, W. W., Reubi, J. C., et al. (1996). Digestion 57(Suppl. 1), 36–37.
Gulec, S. A., Serafini, A. N., Sridhar, K. S., et al. (1998). J. Nucl. Med. 39(2), 243–245.
Kwekkeboom, D. J., Kho, G. S., Lamberts, S. W., Reubi, J. C., Laissue, J. A., and Krenning, E. P. (1994). Eur. J. Nucl. Med. 21(10), 1106–1113.
Bombardieri, E., Crippa, F., Cataldo, I., et al. (1995). Eur. J. Cancer 31A(2), 184–188.
Reisinger, I., Bohuslavitzki, K. H., Brenner, W., et al. (1998). J. Nucl. Med. 39(2), 224–227.
Kirsch, C. M., von Pawel, J., Grau, I., and Tatsch, K. (1994). Eur. J. Nucl. Med. 21(12), 1318–1325.
van Eijck, C. H., Krenning, E. P., Bootsma, A., et al. (1994). Lancet 343(8898), 640–643.
Vanhagen, P. M., Krenning, E. P., Reubi, J. C., et al. (1993). Br. J. Haematol. 83(1), 75–79.
van der Herder, H. E., de Herder, W. W., Bruining, H. A., et al. (2001). J. Clin. Endocrinol. Metab. 86(2), 685–693.
de Herder, W. W., Krenning, E. P., Malchoff, C. D., et al. (1994). Am. J. Med. 96(4), 305–312.
Phlipponneau, M., Nocaudie, M., Epelbaum, J., et al. (1994). J. Clin. Endocrinol. Metab. 78(1), 20–24.
Weiss, M., Yellin, A., Husza’r, M., Eisenstein, Z., Bar-Ziv, J., and Krausz, Y. (1994). Ann. Intern. Med. 121(3), 198–199.
Kwekkeboom, D. J., Krenning, E. P., Kho, G. S., Breeman, W. A., and van Hagen, P. M. (1998). Eur. J. Nucl. Med. 25(9), 1284–1292.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van der Lely, A.J., de Herder, W.W., Krenning, E.P. et al. Octreoscan radioreceptor imaging. Endocr 20, 307–311 (2003). https://doi.org/10.1385/ENDO:20:3:307
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:20:3:307